331 related articles for article (PubMed ID: 2013093)
1. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
Leone A; Flatow U; King CR; Sandeen MA; Margulies IM; Liotta LA; Steeg PS
Cell; 1991 Apr; 65(1):25-35. PubMed ID: 2013093
[TBL] [Abstract][Full Text] [Related]
2. Tumor metastasis and nm23: current concepts.
Steeg PS; Cohn KH; Leone A
Cancer Cells; 1991 Jul; 3(7):257-62. PubMed ID: 1911039
[TBL] [Abstract][Full Text] [Related]
3. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
4. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
[TBL] [Abstract][Full Text] [Related]
5. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
6. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
[TBL] [Abstract][Full Text] [Related]
7. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
Howlett AR; Petersen OW; Steeg PS; Bissell MJ
J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
Guo HB; Liu F; Zhao JH; Chen HL
J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
[TBL] [Abstract][Full Text] [Related]
10. [Expression and anti-metastatic potential of nm 23/NDP kinase in human head and neck cancer cells].
Miyazaki H
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):189-95. PubMed ID: 9711037
[TBL] [Abstract][Full Text] [Related]
11. Nm23 and tumour metastasis: basic and translational advances.
Freije JM; MacDonald NJ; Steeg PS
Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
13. Identification of a second human nm23 gene, nm23-H2.
Stahl JA; Leone A; Rosengard AM; Porter L; King CR; Steeg PS
Cancer Res; 1991 Jan; 51(1):445-9. PubMed ID: 1988104
[TBL] [Abstract][Full Text] [Related]
14. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells.
Parhar RS; Shi Y; Zou M; Farid NR; Ernst P; al-Sedairy ST
Int J Cancer; 1995 Jan; 60(2):204-10. PubMed ID: 7829217
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of signal transduction by the nm23 metastasis suppressor: possible mechanisms.
Salerno M; Ouatas T; Palmieri D; Steeg PS
Clin Exp Metastasis; 2003; 20(1):3-10. PubMed ID: 12650601
[TBL] [Abstract][Full Text] [Related]
16. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
Liu F; Zhang Y; Zhang XY; Chen HL
J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
[TBL] [Abstract][Full Text] [Related]
17. Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma.
Parker C; Sherbet GV
Melanoma Res; 1992 Dec; 2(5-6):337-43. PubMed ID: 1337998
[TBL] [Abstract][Full Text] [Related]
18. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.
Radinsky R; Weisberg HZ; Staroselsky AN; Fidler IJ
Cancer Res; 1992 Oct; 52(20):5808-14. PubMed ID: 1394207
[TBL] [Abstract][Full Text] [Related]
19. Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.
Henderson BR
Br J Cancer; 1993 Nov; 68(5):874-8. PubMed ID: 8217603
[TBL] [Abstract][Full Text] [Related]
20. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
Martinez R; Venturelli D; Perrotti D; Veronese ML; Kastury K; Druck T; Huebner K; Calabretta B
Cancer Res; 1997 Mar; 57(6):1180-7. PubMed ID: 9067290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
